Aura Biosciences, Inc. Share Price & Technical Analysis
AURA · $7.60 (-0.65%)
Healthcare / Biotechnology
$7.60
-0.65%
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the t…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
7% return in May, 8% avg return in past 3 year May month.
36% return in 2026, -13% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | 5% | 18% | 4% | 7% | – | – | – | – | – | – | – | 36% |
| 25 | -7% | -3% | -21% | 0% | 2% | 7% | 11% | -7% | 0% | -2% | 8% | -17% | -29% |
| 24 | -12% | 17% | -15% | -6% | -3% | 1% | 34% | -23% | 13% | 17% | -11% | -13% | -2% |
| 23 | -2% | -2% | -7% | -3% | 24% | 9% | -3% | -13% | -13% | -8% | 0% | 11% | -7% |
| 22 | 5% | -3% | 20% | -24% | 4% | -18% | 2% | -5% | 38% | -31% | 14% | -12% | -9% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Uptrend · Uptrend
Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision therapies to treat solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. It focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer. The company was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$875.23M
P/E ratio
—
52W high
$9.54
52W low
$4.73
Volume
2,78,175
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Aura Biosciences, Inc. share price today?
- Aura Biosciences, Inc. (AURA) last traded around $7.60 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does AURA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AURA. Download the app for real-time alerts.
- How can I analyze Aura Biosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.